Protective effects of milk thistle (Sylibum marianum) seed oil and α-tocopherol against 7β-hydroxycholesterol-induced peroxisomal alterations in murine C2C12 myoblasts: Nutritional insights associated with the concept of pexotherapy.


Journal

Steroids
ISSN: 1878-5867
Titre abrégé: Steroids
Pays: United States
ID NLM: 0404536

Informations de publication

Date de publication:
07 2022
Historique:
received: 25 01 2022
revised: 15 03 2022
accepted: 31 03 2022
pubmed: 6 4 2022
medline: 27 5 2022
entrez: 5 4 2022
Statut: ppublish

Résumé

Peroxisomes play an important role in regulating cell metabolism and RedOx homeostasis. Peroxisomal dysfunctions favor oxidative stress and cell death. The ability of 7β-hydroxycholesterol (7β-OHC; 50 μM, 24 h), known to be increased in patients with age-related diseases such as sarcopenia, to trigger oxidative stress, mitochondrial and peroxisomal dysfunction was studied in murine C2C12 myoblasts. The capacity of milk thistle seed oil (MTSO, 100 μg/mL) as well as α-tocopherol (400 µM; reference cytoprotective agent) to counteract the toxic effects of 7β-OHC, mainly at the peroxisomal level were evaluated. The impacts of 7β-OHC, in the presence or absence of MTSO or α-tocopherol, were studied with complementary methods: measurement of cell density and viability, quantification of reactive oxygen species (ROS) production and transmembrane mitochondrial potential (ΔΨm), evaluation of peroxisomal mass as well as topographic, morphologic and functional peroxisomal changes. Our results indicate that 7β-OHC induces a loss of cell viability and a decrease of cell adhesion associated with ROS overproduction, alterations of mitochondrial ultrastructure, a drop of ΔΨm, and several peroxisomal modifications. In the presence of 7β-OHC, comparatively to untreated cells, important quantitative and qualitative peroxisomal modifications were also identified: a) a reduced number of peroxisomes with abnormal sizes and shapes, mainly localized in cytoplasmic vacuoles, were observed; b) the peroxisomal mass was decreased as indicated by lower protein and mRNA levels of the peroxisomal ABCD3 transporter; c) lower mRNA level of Pex5 involved in peroxisomal biogenesis as well as higher mRNA levels of Pex13 and Pex14, involved in peroxisomal biogenesis and/or pexophagy, was found; d) lower levels of ACOX1 and MFP2 enzymes, implicated in peroxisomal β-oxidation, were detected; e) higher levels of very-long-chain fatty acids, which are substrates of peroxisomal β-oxidation, were found. These different cytotoxic effects were strongly attenuated by MTSO, in the same range of order as with α-tocopherol. These findings underline the interest of MTSO and α-tocopherol in the prevention of peroxisomal damages (pexotherapy).

Identifiants

pubmed: 35381271
pii: S0039-128X(22)00070-8
doi: 10.1016/j.steroids.2022.109032
pii:
doi:

Substances chimiques

Antioxidants 0
Flavonoids 0
Hydroxycholesterols 0
Plant Oils 0
RNA, Messenger 0
Reactive Oxygen Species 0
cholest-5-en-3 beta,7 alpha-diol 566-26-7
alpha-Tocopherol H4N855PNZ1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109032

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Imen Ghzaiel (I)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France; Lab-NAFS 'Nutrition-Functional Food & Vascular Health', Faculty of Medicine, University of Monastir, LR12ES05, 5000 Monastir, Tunisia; Faculty of Sciences of Tunis, University Tunis-El Manar, 2092 Tunis, Tunisia.

Amira Zarrouk (A)

Lab-NAFS 'Nutrition-Functional Food & Vascular Health', Faculty of Medicine, University of Monastir, LR12ES05, 5000 Monastir, Tunisia; Faculty of Medicine, University of Sousse, 4000 Sousse, Tunisia. Electronic address: zarroukamira@gmail.com.

Soukaina Essadek (S)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France; Laboratory of Biochemistry, Neurosciences, Natural Resources and Environment, Faculty of Sciences & Techniques, University Hassan I, BP 577, 26000 Settat, Morocco.

Lucy Martine (L)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21065 Dijon, France.

Souha Hammouda (S)

Lab-NAFS 'Nutrition-Functional Food & Vascular Health', Faculty of Medicine, University of Monastir, LR12ES05, 5000 Monastir, Tunisia.

Aline Yammine (A)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France; Bioactive Molecules Research Laboratory, Doctoral School of Sciences and Technologies, Faculty of Sciences, Lebanese University, Fanar, Jdeidet P.O. Box 90656, Lebanon.

Mohamed Ksila (M)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France; Faculty of Sciences of Tunis, University Tunis-El Manar, 2092 Tunis, Tunisia.

Thomas Nury (T)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France.

Wiem Meddeb (W)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France.

Mounia Tahri Joutey (M)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France; Laboratory of Biochemistry, Neurosciences, Natural Resources and Environment, Faculty of Sciences & Techniques, University Hassan I, BP 577, 26000 Settat, Morocco.

Wafa Mihoubi (W)

Laboratoire de Biotechnologie Moléculaire des Eucaryotes, Centre de Biotechnologie de Sfax, B.P 1177, Université de Sfax, 3018 Sfax, Tunisia.

Claudio Caccia (C)

Laboratory of Clinical Chemistry, Hospitals of Desio, ASST-Brianza and Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.

Valerio Leoni (V)

Laboratory of Clinical Chemistry, Hospitals of Desio, ASST-Brianza and Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.

Mohammad Samadi (M)

LCPMC-A2, ICPM, Department of Chemistry, University Lorraine, Metz Technopôle, 57070 Metz, France.

Niyazi Acar (N)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21065 Dijon, France.

Pierre Andreoletti (P)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France.

Sonia Hammami (S)

Lab-NAFS 'Nutrition-Functional Food & Vascular Health', Faculty of Medicine, University of Monastir, LR12ES05, 5000 Monastir, Tunisia.

Taoufik Ghrairi (T)

Faculty of Sciences of Tunis, University Tunis-El Manar, 2092 Tunis, Tunisia.

Anne Vejux (A)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France.

Mohamed Hammami (M)

Lab-NAFS 'Nutrition-Functional Food & Vascular Health', Faculty of Medicine, University of Monastir, LR12ES05, 5000 Monastir, Tunisia.

Gérard Lizard (G)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism'EA7270/Inserm, University Bourgogne Franche-Comté, 21000 Dijon, France. Electronic address: gerard.lizard@u-bourgogne.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH